P127 Regulatory T cells in non-Hodgkin lymphoma patients
✍ Scribed by L. Gergely; L. Zombori; Zs. Ress; L. Váróczy; Gy. Reményi; S. Baráth; Á. Illés
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 48 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0268-960X
No coin nor oath required. For personal study only.
✦ Synopsis
A total of ten patients died, seven due to progressive disease, two due to unrelated cause, and one due to febrile neutropenia. In mantle zone lymphoma the R in combination with fludara (F) and cyclophosphamide (C) resulted CR lasting for 16 months. The patient with CLL is in CR after R-F-C. Conclusion: R was well tolerated in our patients. The response rates were comparable with results in literature. R is a useful tool in the treatment of lymphoproliferative diseases.
P126 Continuous glucose recordings during steroid pulse therapy (thalidomide/dexamethasone) in myeloma patients
📜 SIMILAR VOLUMES
The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We me
A standard Philadelphia translocation, t(9;22) (q34;qll), was found In lymph node cells from a patient with non-leukemic non-Hodgkln lymphoma at the time of diagnosis. The rearrangement of the breakpoint cluster region (bcr) was not detected with a bcr-3' probe, The neoplastic clone was of monoclona
## Abstract Classical Hodgkin Lymphoma (cHL) is morphologically characterized by a small number of tumour cells, Hodgkin and Reed–Sternberg (HRS) cells, surrounded by numerous tumour‐infiltrating lymphocytes (TIL). The functional role of these TIL is still controversial. While generally considered